Home » Topics » Regulatory » Patents

Patents
RSS

PD-1/PD-L1 interaction inhibitors identified at Bristol Myers Squibb

April 30, 2021

Molecular Skin Therapeutics describes dual kallikrein 5/7 inhibitors

April 30, 2021

New STING receptor antagonists identified at IFM Due

April 30, 2021

Agios Pharmaceuticals and the University of Michigan describe menin/MLL interaction inhibitors

April 29, 2021

Kainos Medicine presents new IRAK-4 inhibitors

April 29, 2021

New Bruton tyrosine kinase inhibitors identified at Newave Pharmaceutical

April 29, 2021

New antiviral compounds discovered at Enanta Pharmaceuticals

April 29, 2021

Bolt Biotherapeutics patents antibody-drug conjugates including TRL7/8 agonists

April 29, 2021

RP Scherer Technologies patents anti-CD25 antibody-maytansine conjugates

April 28, 2021

Domain Therapeutics discovers PTGER4 antagonists

April 28, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...